The impact of external reference pricing on pharmaceutical costs and market dynamics
Growth in the cost of prescription drugs in the US has generated significant interest in the use of external reference pricing (ERP) to tie prices paid for drugs to those in other countries. We used data from the Pricentric ONE™ database, an international drug pricing database, to examine product la...
Main Authors: | Dominic Voehler, Benjamin C. Koethe, Patricia G. Synnott, Daniel A. Ollendorf |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Health Policy Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590229623000059 |
Similar Items
-
How does external reference pricing work in developing countries: evidence from Iran
by: Fatemeh Babaie, et al.
Published: (2023-06-01) -
External reference pricing for medicines in Ukraine: latest trends
by: L. I. Kucherenko, et al.
Published: (2023-11-01) -
IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM?
by: V. V. Omelyanovskiy
Published: (2015-05-01) -
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model
by: Iris an der Heiden, et al.
Published: (2024-04-01) -
The effects of reference pricing on housing market: Evidence from Shenzhen China
by: Arestis Philip, et al.
Published: (2023-01-01)